Skip to main
KMB

Kimberly-Clark (KMB) Stock Forecast & Price Target

Kimberly-Clark (KMB) Analyst Ratings

Based on 14 analyst ratings
Hold
Strong Buy 14%
Buy 7%
Hold 71%
Sell 0%
Strong Sell 7%

Bulls say

Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm, with a strong brand mix and a significant presence in both North America and international markets. The company is facing cost pressures, particularly in the second quarter of 2026, but has strategies in place to mitigate these costs through productivity efforts, pricing adjustments, and renegotiating supplier contracts. Despite a softer market in May, Kimberly-Clark is expected to deliver solid organic sales and earnings growth in the following years, driven by new product innovation and increased merchandising efforts.

Bears say

Kimberly-Clark is facing potential headwinds due to spiking resin costs, with a projected risk of $0.70-0.80 to 2027 EPS. Higher domestic freight costs may also be a risk. The company's recent KVUE acquisition is expected to initially dilute EPS, but there is potential for significant upside in 2028 through identified productivity and synergy savings. The company is already working to identify these savings through combined distribution and logistics, shared procurement, and accelerated top-line growth opportunities, particularly in emerging markets like India.

Kimberly-Clark (KMB) has been analyzed by 14 analysts, with a consensus rating of Hold. 14% of analysts recommend a Strong Buy, 7% recommend Buy, 71% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Kimberly-Clark (KMB) Forecast

Analysts have given Kimberly-Clark (KMB) a Hold based on their latest research and market trends.

According to 14 analysts, Kimberly-Clark (KMB) has a Hold consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $113.79, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $113.79, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Kimberly-Clark (KMB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.